While only a limited number of clinical observational studies or meta-analyses have investigated the correlation between SCF and osteonecrosis or drug-induced osteonecrosis, our current MR analysis presents compelling evidence suggesting that elevated levels of circulating SCF are indeed associated with an increased risk of osteonecrosis. The gene discussed is KITLG; the disease is osteonecrosis.